These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 200791)

  • 1. [The use of photon absorptiometry in renal osteodystrophy (author's transl)].
    Samizadeh A; Loew H; Busch G; Müller H; Losse H
    Klin Wochenschr; 1977 Oct; 55(20):1005-1011. PubMed ID: 200791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy.
    Chesney RW; Moorthy AV; Eisman JA; Jax DK; Mazess RB; DeLuca HF
    N Engl J Med; 1978 Feb; 298(5):238-42. PubMed ID: 201843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on abnormalities of calcium, vitamin D and bone metabolism in patients on maintenance hemodialysis (author's transl)].
    Kitoh C
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):503-18. PubMed ID: 529620
    [No Abstract]   [Full Text] [Related]  

  • 4. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
    Berl T; Berns AS; Hufer WE; Hammill K; Alfrey AC; Arnaud CD; Schrier RW
    Ann Intern Med; 1978 Jun; 88(6):774-80. PubMed ID: 208439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of radial bone mineral content with total body calcium in chronic renal failure.
    Cohn SH; Ellis KJ; Caselnova RC; Asad SN; Letteri JM
    J Lab Clin Med; 1975 Dec; 86(6):910-9. PubMed ID: 1194756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteodystrophy of dialysed patients treated with vitamin D.
    Verberckmoes R; Bouillon R; Krempien B
    Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
    Offermann G; Schaefer K; Schulz A; Delling G
    Klin Wochenschr; 1976 Jul; 54(13):625-32. PubMed ID: 940299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G; Bianchi ML; Valenti G
    Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of vitamin D therapy on renal osteodystrophy in children (author's transl)].
    Bulla M; Stock GJ; Delling G; Hofmann H; Offermann G
    Klin Wochenschr; 1980 Mar; 58(5):237-47. PubMed ID: 6249957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral content in patients on prolonged maintenance hemodialysis: a three year follow-up study.
    Rickers H; Christensen M; Rødbro P
    Clin Nephrol; 1983 Dec; 20(6):302-7. PubMed ID: 6641032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 1alpha-hydroxyvitamin D3 on calcium and mineral content of bone in renal osteodystrophy.
    Junor BJ; Catto GR
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():131s-138s. PubMed ID: 606411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].
    Sebert JL; Fournier AE; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(38):3533-7. PubMed ID: 341079
    [No Abstract]   [Full Text] [Related]  

  • 13. [Markers of calcium--phosphate metabolism and bones alterations in long term kidney transplant patients].
    Spiechowicz U; Kokot F; Wiecek A
    Przegl Lek; 2003; 60(11):690-4. PubMed ID: 15058034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
    Bordier P; Zingraff J; Gueris J; Jungers P; Marie P; Pechet M; Rasmussen H
    Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estimation of bone mineral content by means of 125I photon absorption measurements in normals (author's transl)].
    Roth AV; Ringe JD; Kruse HP; Kuhlencordt F
    Fortschr Geb Rontgenstr Nuklearmed; 1974 Nov; 121(5):597-603. PubMed ID: 4375085
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on calcium-regulating hormone in patients on chronic hemodialysis with special reference to renal osteodystrophy (ROD) (author's transl)].
    Kudo S
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):181-96. PubMed ID: 7098141
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in bone mineral content evaluated by photon absorptiometry before the start of active uremia treatment.
    Lindergård B
    Clin Nephrol; 1981 Sep; 16(3):126-30. PubMed ID: 7296969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiological changes of mineral content of radius and ulna in relation to age and sex (author's transl)].
    Ringe JD; Rehpenning W; Kuhlencordt F
    Rofo; 1977 Apr; 126(4):376-80. PubMed ID: 140133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral loss during maintenance hemodialysis.
    Rickers H; Nielsen AH; Smith Pederson R; Rødbro P
    Acta Med Scand; 1978; 204(4):263-7. PubMed ID: 696426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study on bone mineral mass in metabolic bone disorders--I-125 photon absorptiometry].
    Kishimoto H
    Nihon Seikeigeka Gakkai Zasshi; 1983 Nov; 57(11):1699-715. PubMed ID: 6676388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.